Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-35.62	58.52	90.90
Graham Fair Price	16.18	21.54	18.54
PEG	3858.79	0.92	-0.02
Price/Book	-6.02	1.30	1.38
Price/Cash Flow	426.19	353.35	-67.15
Prices/Earnings	-32.24	33.29	49.13
Price/Sales	-6.90	4.37	4.69
Price/FCF	426.19	353.35	-67.15
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.38	0.81	0.82
Operating Margin	29146.02	0.04	< 0.005
ROA	56.56	< 0.005	< 0.005
ROE	< 0.005	< 0.005	38.70
ROIC	< 0.005	< 0.005	26890.80
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.17	-0.36	-52.65
Dividends QOQ	< 0.005	< 0.005	266.14
EBIT QOQ	0.91	292.50	32074.86
EPS QOQ	21.25	0.36	-98.29
FCF QOQ	-1.65	1.18	-28.71
Revenue QOQ	-0.04	< 0.005	90.62
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-1457.51	-633.89	56.51
Days Sales Outstanding (DSO)	36.84	27.60	-25.10
Inventory Turnover	-0.06	-0.14	-129.93
Debt/Capitalization	0.32	0.30	-4.21
Quick Ratio	3.76	1.04	-72.46
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	46.62	45.99	-1.35
Cash	40.79	15.38	-62.30
Capex	-0.56	-0.50	11.10
Free Cash Flow	-0.96	0.17	-82.38
Revenue	13.74	13.68	-0.42
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.81	1.46	-48.09
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-44.77	1.15	-97.42
Naive Interpretation	Member

06 - Financial Health · Weak

Rating